Actively Recruiting
Intermittent Hypoxia Training for Mild Cognitive Impairment in Adults Aged 55 to 79
Led by University of North Texas Health Science Center · Updated on 2026-04-29
66
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating intermittent hypoxia training IHT as a potential treatment for adults aged 55 to 79 years who have mild cognitive impairment MCI. This phase I clinical trial aims to assess the safety and effects of IHT on cognitive functions such as memory, concentration, visuospatial orientation, and executive function. The study will also explore cardiovascular and brain changes related to the treatment. Participants will be randomly assigned to one of two groups the IHT group or a control group receiving sham-IHT. Those in the IHT group will breathe air with reduced oxygen 10% O2 intermittently for up to 5 minutes, alternating with 5 minutes of normal air, for 8 cycles per session, three sessions per week, over 12 weeks. The control group will receive similar sessions but breathe normal oxygen levels 21% O2 instead. Cognitive and physiological assessments will be conducted before, during, and after the 12-week intervention, including brain MRI and blood tests. During the study, participants will complete cognitive tests at multiple points, including after 5, 8, and 12 weeks of treatment, to evaluate changes over time. Researchers will also monitor cardiovascular function during various challenges and assess blood markers and brain structure. The total commitment includes multiple lab visits for treatment sessions and assessments. The main outcomes focus on changes in cognitive performance after the 12-week intervention period.
CONDITIONS
Brief Title
IHT for Mild Cognitive Impairment
Research Team
X
Xiangrong Shi, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here